Our Cell & Gene Therapy division has implemented a risk-based, precision-driven logistics model that leverages multimodal solutions to ensure the safe, timely, and fully compliant delivery of advanced therapies across Europe.

Because these therapies are living, high-value, and irreplaceable, our approach guarantees total traceability and zero margin for error at every stage of the logistics process.